Investmark Advisory Group’s Organon & Co OGN Stock Holding History

Investmark Advisory Group’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-23	Closed	–	–	281
2021 Q4	$0	Buy	+23	New	+$749	﹤0.01%	381

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Investmark Advisory Group's OGN Position: Q1 2022 in Review

Investmark Advisory Group sold out of Organon & Co (OGN) in Q1 2022, closing a stake of 23 shares.

Investmark Advisory Group first reported a position in OGN in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 818 funds tracked by Wall St. Rank hold OGN as of Q1 2022.

Investmark Advisory Group reported no remaining Organon & Co position as of Q1 2022 after selling out during the quarter.
Investmark Advisory Group sold 23 Organon & Co shares in Q1 2022.
Investmark Advisory Group first reported a position in Organon & Co in Q4 2021 and held it in 1 quarter.
Investmark Advisory Group's Organon & Co position peaked at $0 in Q4 2021.
818 funds tracked by Wall St. Rank held Organon & Co as of Q1 2022.

Based on Investmark Advisory Group's 13F filing for Q1 2022, filed 3 May 2022.